EARLY-STAGE INNOVATIONS | ACADEMIA-INDUSTRY COLLABORATIONS | TECHNOLOGY TRANSFER | SEED INVESTMENT
With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
Out of 1,000 BioFIT attendees, 1,000 deals have been generated. The breakdown in terms of nature of deals is the following:
- 35% of collaborative research projects
- 30% of licensing deals
- 15% of equity investment deals
- 20% of services deals
Estimate based on the measurement of 2015 and 2016 delegates’ outcomes
KEY FIGURES:
- 1,200+ delegates
- 800+ organisations
- 35+ countries represented
- 1,000 deals generated in 2017
INSIDE THE EVENT:
- A business convention with pre-qualified one-to-one meetings (partneringONE platform from EBD Group)
- Identification of would-be CEOs
- Conferences and roundtable discussions
- Oral presentations of start-ups and licensing opportunities stemming from academia
- An exhibition area
- Informal networking evenings
Website: www.biofit-event.com
Twitter: @BIOFIT_EVENT
Contact:
Margaux Satola
Business Development Manager
msatola@eurasante.com
+33 (0)3 59 39 01 82